BDX vs SON · P/E 34, rev $21.84B vs P/E 57, rev $1.36B
Becton Dickinson and Company (BDX) versus Sonoco Products Company (SON) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Sonoco Products Company (SON) is a packaging & containers company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported SON revenue for 2024-12-31 was $1.36B. Net income was $163.9M. Revenue was up 0.6% from 2024-09-29 to 2024-12-31. SON currently screens at market cap $4.59B and trailing P/E 56.7.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. SON currently screens at market cap $4.59B and trailing P/E 56.7.
Not investment advice. Open the BDX and SON stock pages for the full models.
Not investment advice.